Skip to main content

Advertisement

Log in

Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomography

  • Medical Ophthalmology
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to compare the morphology of the central and peripheral choroid of eyes with central serous chorioretinopathy (CSC) to that of normal eyes using ultra-widefield optical coherence tomography (UWF-OCT).

Methods

We reviewed the medical records of 29 eyes of 25 patients (23 men, 2 women; average age 44.4 years) with CSC and 34 eyes of 22 healthy subjects (19 men, 3 women; average age, 49.5 years) with normal eyes. The images obtained by a prototype swept source UWF-OCT (Topcon, Tokyo, Japan) of about 31.5-mm wide and a depth of 10.9 mm were analyzed. The choroidal thickness was measured for each sector of the eye using the conventional automated layer analysis method. The local morphological differences were quantified by the maximum steepness (µm/deg) which was obtained by differentiating the changes in the choroidal thickness from the periphery to the fovea. Only the vertical scans were evaluated to avoid the influence of the optic disc.

Results

The choroid was thicker in the macular area than the peripheral area in both normal and CSC eyes. The choroid at the subfovea was significantly thicker in the CSC eyes than that of the normal eyes (P < 0.0001); however, the difference at the periphery was not significant. The mean of the maximum steepness of the choroidal thickness was 20.8 ± 3.8 µm/deg in the CSC eyes which was significantly steeper than the 16.0 ± 4.6 µm/deg in healthy eyes (P < 0.0001).

Conclusion

The choroid in CSC eyes has a steeper slope around the posterior pole. UWF-OCT can be used to evaluate the abnormalities of the choroidal structures from the posterior pole to the periphery in eyes with CSC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yannuzzi LA (1986) Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 84:799–845

    PubMed  PubMed Central  CAS  Google Scholar 

  2. Carvalho-Recchia CA, Yannuzzi LA, Negrão S et al (2002) Corticosteroids and central serous chorioretinopathy. Ophthalmology 109:1834–1837. https://doi.org/10.1016/S0161-6420(02)01117-X

    Article  PubMed  Google Scholar 

  3. Izumi T, Koizumi H, Takahashi Y et al (2018) Differences in choroidal structures between idiopathic and steroid-induced central serous chorioretinopathy. J Vitreoretin Dis 3:10–15. https://doi.org/10.1177/2474126418818348

    Article  Google Scholar 

  4. Piccolino FC, Borgia L (1994) Central serous chorioretinopathy and indocyanine green angiography. Retina 14:231–242. https://doi.org/10.1097/00006982-199414030-00008

    Article  PubMed  CAS  Google Scholar 

  5. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D (1994) Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 112:1057–1062. https://doi.org/10.1001/archopht.1994.01090200063023

    Article  PubMed  CAS  Google Scholar 

  6. Prunte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121:26–34. https://doi.org/10.1016/s0002-9394(14)70531-8

    Article  PubMed  CAS  Google Scholar 

  7. Iida T, Kishi S, Hagimura N, Shimizu K (1999) Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19:508–512. https://doi.org/10.1097/00006982-199911000-00005

    Article  PubMed  CAS  Google Scholar 

  8. Spaide RF, Koizumi H, Pozonni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496–500. https://doi.org/10.1016/j.ajo.2008.05.032

    Article  PubMed  Google Scholar 

  9. Yasuno Y, Miura M, Kawana K et al (2009) Visualization of sub-retinal pigment epithelium morphologies of exudative macular diseases by high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci 50:405–413. https://doi.org/10.1167/iovs.08-2272

    Article  PubMed  Google Scholar 

  10. Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29:1469–1473. https://doi.org/10.1097/IAE.0b013e3181be0a83

    Article  PubMed  Google Scholar 

  11. Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T (2011) Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 31:1603–1608. https://doi.org/10.1097/IAE.0b013e31820f4b39

    Article  PubMed  Google Scholar 

  12. Sonoda S, Sakamoto T, Kuroiwa N et al (2016) Structural changes of inner and outer choroid in central serous chorioretinopathy determined by optical coherence tomography. PLoS ONE. https://doi.org/10.1371/journal.pone.0157190

    Article  PubMed  PubMed Central  Google Scholar 

  13. Izumi T, Koizumi H, Maruko I et al (2017) Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy. Br J Ophthalmol 101:433–437. https://doi.org/10.1136/bjophthalmol-2016-308921

    Article  PubMed  Google Scholar 

  14. Pang CE, Shah VP, Sarraf D, Freund KB (2014) Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy. Am J Ophthalmol 158:362–371. https://doi.org/10.1016/j.ajo.2014.04.021

    Article  PubMed  Google Scholar 

  15. Hiroe T, Kishi S (2018) Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmology Retina 2:152–161. https://doi.org/10.1016/j.oret.2017.05.013

    Article  PubMed  Google Scholar 

  16. Hirahara S, Yasukawa T, Kominami A, Nozaki M, Ogura Y (2016) Densitometry of choroidal vessels in eyes with and without central serous chorioretinopathy by wide-field indocyanine green angiography. Am J Ophthalmol 166:103–111. https://doi.org/10.1016/j.ajo.2016.03.040

    Article  PubMed  Google Scholar 

  17. Manayath GJ, Arora S, Parikh H, Shah PK, Tiwari S, Narendran V (2016) Is myopia a protective factor against central serous chorioretinopathy? Int J Ophthalmol 9:266–270. https://doi.org/10.18240/ijo.2016.02.16

    Article  PubMed  PubMed Central  Google Scholar 

  18. Elagouz M, Stanescu-Segall D, Jackson TL (2010) Uveal effusion syndrome. Surv Ophthalmol 55:134–145. https://doi.org/10.1016/j.survophthal.2009.05.003

    Article  PubMed  Google Scholar 

  19. Pautler SE, Browning DJ (2014) Isolated posterior uveal effusion: expanding the spectrum of the uveal effusion syndrome. Clin Ophthalmol 9:43–49. https://doi.org/10.2147/OPTH.S75448

    Article  PubMed  PubMed Central  Google Scholar 

  20. Shields CL, Roelofs K, Di Nicola M, Sioufi K, Mashayekhi A, Shields JA (2017) Uveal effusion syndrome in 104 eyes: response to corticosteroids - the 2017 Axel C. Hansen lecture Indian J Ophthalmol 65:1093–1104. https://doi.org/10.4103/ijo.IJO_752_17

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Professor Emeritus Duco Hamasaki of the Bascom Palmer Eye Institute, University of Miami, for his critical discussion and editing of the revised manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ichiro Maruko.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of the Tokyo Women’s Medical University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

Izumi: Personal fees from Novartis (Japan), Senju (Japan), outside the submitted work.

Maruko: Grants from JSPS KAKENHI (Grant Number JP 20K09781), grants and personal fees from Alcon Pharma (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), personal fees from Santen Pharmaceutical Inc. (Japan), personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd. (Japan), personal fees from Senju Pharmaceutical Co. (Japan), Ltd., personal fees from NIDEK Co., Ltd. (Japan), outside the submitted work. Maruko has a patent Peripheral retinal imaging system pending.

Kawano: Personal fees from Senju (Japan), outside the submitted work.

Sakaihara: Employee by Topcon Corp.

Iida.: Consultant- Bayer (Japan), Chugai (Japan); Research support from Topcon (Japan); Personal fees from Bayer (Japan), Novartis (Japan), Nidek (Japan), Kowa (Japan), Canon (Japan), Topcon (Japan), Santen (Japan), Senju (Japan), Alcon (Japan), HOYA (Japan), AMO (Japan), Pfizer (Japan), Otsuka (Japan), JFC (Japan), Nikon (Japan), outside the submitted work. Iida has a patent Peripheral retinal imaging system pending.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Izumi, T., Maruko, I., Kawano, T. et al. Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 260, 295–301 (2022). https://doi.org/10.1007/s00417-021-05380-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-021-05380-0

Keywords

Navigation